TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA WITH A DAUNORUBICIN-CYTARABINE-6 THIOGUANINE REGIMEN WITHOUT MAINTENANCE THERAPY

被引：4
|
作者：
FREUND, M [1 ]
POLIWODA, H [1 ]
BODENSTEIN, H [1 ]
EISERT, R [1 ]
机构：
[1] MED CTR,DEPT 4,MINDEN,FED REP GER
来源：
ONKOLOGIE | 1985年 / 8卷 / 03期
关键词：
D O I：
10.1159/000215643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 152
页数：3
相关论文
共 50 条
  • [21] POSTREMISSION THERAPY OF ACUTE MYELOCYTIC-LEUKEMIA IN ADULTS - CURABILITY BREEDS CONTROVERSY
    GELLER, RB
    LEUKEMIA, 1992, 6 (09) : 915 - 925
  • [22] THERAPY OF ACUTE MYELOCYTIC LEUKEMIA - DAUNOMYCIN CONTRASTED WITH A COMBINATION OF CYTOSINE-ARABINOSIDE AND 6-THIOGUANINE
    POTH, JL
    JOHNSON, PK
    GEORGE, RP
    SCHRIER, SL
    CALIFORNIA MEDICINE, 1972, 117 (06): : 1 - 11
  • [23] Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report
    Yang, Xia
    Liu, Wei
    Lyons, Allie
    Song, Zaiwei
    Zhai, Suodi
    Hu, Kai
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (02) : 181 - 182
  • [24] Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report
    Xia Yang
    Wei Liu
    Allie Lyons
    Zaiwei Song
    Suodi Zhai
    Kai Hu
    European Journal of Clinical Pharmacology, 2018, 74 : 181 - 182
  • [25] A 2-STEP TIMED SEQUENTIAL TREATMENT FOR ACUTE MYELOCYTIC-LEUKEMIA
    GELLER, RB
    BURKE, PJ
    KARP, JE
    HUMPHREY, RL
    BRAINE, HG
    TUCKER, RW
    FOX, MG
    ZAHURAK, M
    MORRELL, L
    HALL, KL
    PIANTADOSI, S
    BLOOD, 1989, 74 (05) : 1499 - 1506
  • [26] THE TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA IN PATIENTS 30 YEARS OF AGE AND YOUNGER
    PREISLER, HD
    BRECHER, M
    BROWMAN, G
    EARLY, AP
    WALKER, IR
    RAZA, A
    FREEMAN, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1982, 13 (03) : 189 - 198
  • [27] ACUTE MYELOCYTIC-LEUKEMIA AFTER THE USE OF CYCLOPHOSPHAMIDE IN THE TREATMENT OF POLYARTERITIS NODOSA
    ESCALANTE, A
    KAUFMAN, RL
    BEARDMORE, TD
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (08) : 1147 - 1149
  • [28] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Krogh-Madsen, Mikkel
    Bender, Brendan
    Jensen, Morten Krogh
    Nielsen, Ove Juul
    Friberg, Lena E.
    Honore, Per Hartvig
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1155 - 1163
  • [29] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Mikkel Krogh-Madsen
    Brendan Bender
    Morten Krogh Jensen
    Ove Juul Nielsen
    Lena E. Friberg
    Per Hartvig Honoré
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1155 - 1163
  • [30] AMSACRINE, CYTARABINE AND THIOGUANINE (AAT) VERSUS DAUNORUBICIN, CYTARABINE, THIOGUANINE (DAT) IN ADULTS WITH UNTREATED ACUTE NON-LYMPHOBLASTIC LEUKEMIA (ANLL) - AUSTRIAN-GERMAN RESULTS
    LINKESCH, W
    MICHLMAYR, G
    GERHARTZ, H
    ILLINGER, H
    KONIG, H
    DULLMANN, J
    KEILHAUER, R
    MOLDRZYK, D
    ONKOLOGIE, 1989, 12 (01): : 8 - 10
12345